The Case Against (and for) Donald Berwick
The White House has released a seven-page, single-spaced document that lists more than 200 organizations that support Berwick’s nomination. Here are some of the ones that really matter: AARP, AMA, AHA, AHIP, Medical Group Management Association and the American Public Health Association. When was the last time they all agreed on anything?
Why he should stay: It looks like Berwick can get everyone to the table and that is vitally important as ACA moves to implementation.
Why he should go: No downside here.
Why it may not matter: Berwick can stay right where he is until the end of 2011. By then he will have filled his management positions with people who pretty much think like him. Marilyn Tavenner, who is now second in charge at CMS, would probably become the acting director. Also, the Obama administration has tucked the Office of Consumer Information and Insurance Oversight into a safe place within the mammoth CMS. It is a preemptive move to counter legislative efforts to defund the office, which is charged with developing healthcare reform rules and regs. Steve Larsen, the widely respected and consumer-friendly former Maryland insurance commissioner, heads that office and has already issued a first round of rules.
Why it does matter: His supporters consider Berwick a visionary and an innovator in terms of patient-centered quality healthcare. As the head of CMS he will have the final say over what pilot projects are funded through the new Center for Medicare and Medicaid Innovation. That is important because much of the heavy lifting in terms of policy development will be formed around the successful pilots.
Berwick's chances for confirmation depend more on politics than anything else.
- Readmissions: No Quick Fix to Costly Hospital Challenge
- Ebola: Health Officials Try to Quell Front Line Fears
- How Telehealth Pays Off for Providers, Patients
- House Calls Key to Pioneer ACO Success
- Defensive Medicine Still Prevalent Despite Tort Reform
- Reducing Readmissions Starts with Better Collaboration
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- How Top-Ranked MA Plans Earn Their Stars
- Partners HealthCare M&A Deal Under Scrutiny
- How Educated Nurses Save Money